Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Clofazimine may be effective for treating ashy dermatosis.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Combining pentoxifylline with corticosteroids improves alopecia areata treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Probiotics significantly reduce the severity of atopic dermatitis.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

An oil-in-water emulsion with CBD and ginger root extract significantly improved symptoms of dry and eczema-prone skin.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

JAK inhibitors may reduce depression in people with alopecia areata.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Inclisiran is effective at lowering cholesterol.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Tofacitinib might be used to treat hair loss.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.